ArticleInternational journal of women's health2025
Global Trends in the Epidemiologic Burden of Anxiety Disorders Among Women of Childbearing Age (1990-2021): Associations with Sociodemographic Index.
Article in International journal of women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anxiety disorders have become a severe global public health issue, especially pronounced among women of childbearing age (WCBA). However, comprehensive studies on the global burden and temporal trends of anxiety disorders in this demographic remain scarce. Methods: Data on the prevalence, incidence, and disability-adjusted life years (DALYs) associated with anxiety disorders among WCBA from 1990 to 2021 were extracted from the Global Burden of Disease (GBD) database. The estimated annual percentage change (EAPC) was calculated to assess trends in the burden of anxiety disorders, with 95% uncertainty intervals provided for point estimates. Results: As of 2021, the global prevalence, incidence, and DALYs of anxiety disorders among WCBA were 138.3 million, 18.96 million, and 16.45 million cases, respectively-reflecting increases of 77%, 77%, and 76% since 1990. The global burden of the three indicators of prevalence, incidence and DALYs for anxiety disorders showed a significant upward trend, with EAPCs of 0.18 (95% CI: 0.02-0.33), 0.21 (95% CI: 0.06-0.36) and 0.17 (95% CI: 0.02-0.32), respectively. Countries with a middle sociodemographic index (SDI) had the highest burden, while low-middle SDI countries experienced the fastest growth rate. Among the 21 global regions, most displayed an upward trend in all three metrics, with Mexico exhibiting the most significant increase, despite decreases in some countries. Conclusion: Over the past 32 years, the global burden of anxiety disorders among WCBA has significantly increased, particularly in middle SDI countries and among women aged 45-49.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.